Skip to main content

Lynx Inks Gene-Expression Collaboration with Ludwig Cancer Institute

NEW YORK, July 18 - Lynx Therapeutics today said it will collaborate with the Ludwig Institute for Cancer Research to study cancer gene expression.

 

The LICR will pay Lynx to apply its MPSS tool to uncover differentially expressed genes in cancer samples.

 

Lynx is already engaged in a similar collaboration with the National Cancer Institute.

 

Click here for more information.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.